Carregant...
Efficacy and safety of Naoxintong capsule for treating chronic stable angina: study protocol for a randomized controlled trial
BACKGROUND: Cardiovascular disease is the leading cause of mortality and morbidity worldwide, Chronic stable angina (CSA) is the main symptom of myocardial ischemia, causes increased risk of major cardiovascular events such as sudden cardiac death and myocardial infarction. Naoxintong (NXT) capsule...
Guardat en:
| Publicat a: | Trials |
|---|---|
| Autors principals: | , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8112004/ https://ncbi.nlm.nih.gov/pubmed/33971940 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13063-021-05264-y |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|